A review on the clinical uses of SPECT/CT

G Mariani, L Bruselli, T Kuwert, EE Kim… - European journal of …, 2010 - Springer
In the era when positron emission tomography (PET) seems to constitute the most advanced
application of nuclear medicine imaging, still the conventional procedure of single photon …

Clinical applications of PET in brain tumors

W Chen - Journal of nuclear medicine, 2007 - Soc Nuclear Med
Malignant gliomas and metastatic tumors are the most common brain tumors. Neuroimaging
plays a significant role clinically. In low-grade tumors, neuroimaging is needed to evaluate …

Malignant gliomas: current perspectives in diagnosis, treatment, and early response assessment using advanced quantitative imaging methods

R Ahmed, MJ Oborski, M Hwang… - Cancer management …, 2014 - Taylor & Francis
Malignant gliomas consist of glioblastomas, anaplastic astrocytomas, anaplastic
oligodendrogliomas and anaplastic oligoastrocytomas, and some less common tumors such …

Tumor cell metabolism imaging

C Plathow, WA Weber - Journal of Nuclear Medicine, 2008 - Soc Nuclear Med
Molecular imaging of tumor metabolism has gained considerable interest, since preclinical
studies have indicated a close relationship between the activation of various oncogenes and …

Performance of 18F-fluoro-ethyl-tyrosine (18F-FET) PET for the differential diagnosis of primary brain tumor: a systematic review and Metaanalysis

V Dunet, C Rossier, A Buck, R Stupp… - Journal of Nuclear …, 2012 - Soc Nuclear Med
For the past decade, PET with 18F-fluoro-ethyl-tyrosine (18F-FET) has been used in the
evaluation of patients with primary brain tumors (PBTs), but so far series have reported only …

O-(2-[18F] fluoroethyl)-L-tyrosine: uptake mechanisms and clinical applications

KJ Langen, K Hamacher, M Weckesser, F Floeth… - Nuclear medicine and …, 2006 - Elsevier
O-(2-[18F] fluoroethyl)-l-tyrosine (FET) is a promising tracer for PET that has demonstrated
convincing results especially in the diagnostics of brain tumors. In contrast to other …

Performance of 18F-FET versus 18F-FDG-PET for the diagnosis and grading of brain tumors: systematic review and meta-analysis

V Dunet, A Pomoni, A Hottinger… - Neuro …, 2015 - academic.oup.com
Background For the past decade 18F-fluoro-ethyl-l-tyrosine (FET) and 18F-fluoro-deoxy-
glucose (FDG) positron emission tomography (PET) have been used for the assessment of …

[HTML][HTML] PET imaging of inflammation biomarkers

C Wu, F Li, G Niu, X Chen - Theranostics, 2013 - ncbi.nlm.nih.gov
Inflammation plays a significant role in many disease processes. Development in molecular
imaging in recent years provides new insight into the diagnosis and treatment evaluation of …

Treatment Response Evaluation Using 18F-FDOPA PET in Patients with Recurrent Malignant Glioma on Bevacizumab Therapy

J Schwarzenberg, J Czernin, TF Cloughesy… - Clinical Cancer …, 2014 - AACR
Purpose: This study compares the value of 3, 4-dihydroxy-6-[18F]-fluoro-l-phenylalanine
(18F-FDOPA) positron emission tomography (PET) and MRI in assessing outcome during …

Differentiating radiation necrosis from tumor recurrence in high-grade gliomas: assessing the efficacy of 18F-FDG PET, 11C-methionine PET and perfusion MRI

YH Kim, SW Oh, YJ Lim, CK Park, SH Lee… - Clinical neurology and …, 2010 - Elsevier
PURPOSE: The authors analyzed the characteristics of perfusion magnetic resonance
imaging (MRI), 18F-fluorodeoxyglucose (FDG) positron emission tomography (PET) and …